Prosecution Insights
Prosecution Insights
Tech Center 3900 • Art Units: 1611 1658 3991
This examiner grants 25% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16120549 | GROWTH DIFFERENTIATION FACTOR 11 (GDF-11) FOR TREATMENT OF DIASTOLIC HEART FAILURE | Non-Final OA | President and Fellows of Harvard College |
| 18185343 | PEPTIDES, DEVICES, AND METHODS FOR THE DETECTION OF EHRLICHIA ANTIBODIES | Non-Final OA | Zoetis Services LLC |
| 18282152 | REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V | Non-Final OA | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM |
| 18530761 | METHODS TO GENERATE GASTROINTESTINAL EPITHELIAL TISSUE CONSTRUCTS | Non-Final OA | The University of North Carolina at Chapel Hil |
| 18491078 | Nucleic Acid Molecules Encoding Indoleamine 2,3-Dioxygenase-2 | Non-Final OA | LANKENAU INSTITUTE FOR MEDICAL RESEARCH |
| 18229565 | ANTI-HUMAN IL-3 ANTIBODIES, THEIR USE IN TREATMENT OF A DISEASE OR MALFUNCTION ASSOCIATED WITH ELEVATED EXPRESSION OR LEVELS OF IL-3, AND THEIR USE IN A METHOD TO DETECT HUMAN IL-3 | Non-Final OA | Universitätsklinikum Regensburg |
| 18115342 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS | Non-Final OA | XLINK Therapeutics, Inc. |
| 18150988 | CELL PRESERVATION REAGENTS AND METHODS OF USE | Non-Final OA | Truckee Applied Genomics, LLC |
| 17819591 | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | Final Rejection | ProThera Biologics, Inc. |
| 17336491 | COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAIN | Non-Final OA | ESTEVE PHARMACEUTICALS, S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy